» Articles » PMID: 20173736

Targeted Deletion of the 9p21 Non-coding Coronary Artery Disease Risk Interval in Mice

Overview
Journal Nature
Specialty Science
Date 2010 Feb 23
PMID 20173736
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk of coronary artery disease (CAD), the leading cause of death worldwide. The variants have a substantial effect on the epidemiology of CAD and other life-threatening vascular conditions because nearly one-quarter of Caucasians are homozygous for risk alleles. However, the risk interval is devoid of protein-coding genes and the mechanism linking the region to CAD risk has remained enigmatic. Here we show that deletion of the orthologous 70-kb non-coding interval on mouse chromosome 4 affects cardiac expression of neighbouring genes, as well as proliferation properties of vascular cells. Chr4(Delta70kb/Delta70kb) mice are viable, but show increased mortality both during development and as adults. Cardiac expression of two genes near the non-coding interval, Cdkn2a and Cdkn2b, is severely reduced in chr4(Delta70kb/Delta70kb) mice, indicating that distant-acting gene regulatory functions are located in the non-coding CAD risk interval. Allele-specific expression of Cdkn2b transcripts in heterozygous mice showed that the deletion affects expression through a cis-acting mechanism. Primary cultures of chr4(Delta70kb/Delta70kb) aortic smooth muscle cells exhibited excessive proliferation and diminished senescence, a cellular phenotype consistent with accelerated CAD pathogenesis. Taken together, our results provide direct evidence that the CAD risk interval has a pivotal role in regulation of cardiac Cdkn2a/b expression, and suggest that this region affects CAD progression by altering the dynamics of vascular cell proliferation.

Citing Articles

The oral microbiota: new insight into intracranial aneurysms.

Gong W, Yu H, You W, Chen Z, Wang Y, Liu C Ann Med. 2025; 57(1):2451191.

PMID: 39803910 PMC: 11731255. DOI: 10.1080/07853890.2025.2451191.


The senescent marker p16INK4a enhances macrophage foam cells formation.

Siew W, Tang Y, Goh B, Yap W Mol Biol Rep. 2024; 51(1):1021.

PMID: 39331194 DOI: 10.1007/s11033-024-09946-z.


Functional Genomics in Psoriasis.

Rossi S, Richards E, Orozco G, Eyre S Int J Mol Sci. 2024; 25(13).

PMID: 39000456 PMC: 11242296. DOI: 10.3390/ijms25137349.


Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice.

Kettunen S, Suoranta T, Beikverdi S, Heikkila M, Slita A, Raty I Cells. 2024; 13(11.

PMID: 38891115 PMC: 11171903. DOI: 10.3390/cells13110983.


The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic state.

Salido E, de Medeiros Vieira C, Mosquera J, Zade R, Parikh P, Suryavanshi S bioRxiv. 2024; .

PMID: 38853913 PMC: 11160673. DOI: 10.1101/2024.05.25.595888.


References
1.
Topol E, Smith J, Plow E, Wang Q . Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet. 2006; 15 Spec No 2:R117-23. DOI: 10.1093/hmg/ddl183. View

2.
Helgadottir A, Thorleifsson G, Magnusson K, Gretarsdottir S, Steinthorsdottir V, Manolescu A . The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008; 40(2):217-24. DOI: 10.1038/ng.72. View

3.
Liu Y, Sanoff H, Cho H, Burd C, Torrice C, Mohlke K . INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One. 2009; 4(4):e5027. PMC: 2660422. DOI: 10.1371/journal.pone.0005027. View

4.
Diez-Juan A, Andres V . The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis. FASEB J. 2001; 15(11):1989-95. DOI: 10.1096/fj.01-0130com. View

5.
Sharpless N, Ramsey M, Balasubramanian P, Castrillon D, DePinho R . The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene. 2004; 23(2):379-85. DOI: 10.1038/sj.onc.1207074. View